SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bentway who wrote (615796)6/14/2011 12:51:37 AM
From: TimF  Read Replies (1) of 1580032
 
Pointing to harm from early or faulty drug approval and use is not enough to make an argument against streamlining the drug approval process.

Yes if you approve drugs with less time and expense some people will be harmed or killed, who might not have been without the use of the drug.

OTOH people also die or suffer because drugs that could help them are not approved, or not even developed in the first place because of the large cost to develop and test new drugs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News